Company intelligence / Profile preview

Bajaj Healthcare

Mumbai, Maharashtra, India

Ownership: Private
Employees: ~1173
Development stage: Other

Overview

Bajaj Healthcare is a commercial-stage Indian pharma company specializing in the development, manufacture, and global supply of small molecule APIs, intermediates, finished dosage forms, and nutraceutical ingredients, with 17+ commercial products and at least 10 advanced pipeline programs, including peptide APIs for metabolic and neurological diseases. It exports to over 45 countries and holds multiple regulatory certificates (GMP, EU-GMP, KFDA, WHO-GMP, CEP).

Therapeutic areas: ImmunologyEndocrinologyPsychiatryInfectious DiseasesGastroenterologyOtherNeurologyUrology
Modalities: Small moleculePeptides
Industry: Biotech

Partnerships

Not specifically disclosed in public sources; no major global pharma partners indicated in recent disclosures[6][2].

Beyond the preview

Go deeper on Bajaj Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bajaj Healthcare.

Explore the full profile